publication date: Dec. 26, 2010

In this issue: 

Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?

Cornell, MSKCC, Rockefeller To collaborate In $160M Basic Biological Research Program.

North General, MSK, Form Cancer Prevention Center.

Human Genome Consortium Completes “Working Draft”.

NCI Plans $40M In Grants For Cancer Outcomes Studies.

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.

Sustained-Release Leuprolide Under Study In Phase III Trial.

Celgene Signs CRADA With NCI For Development Of CDC-501.

Download (PDF 282KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.